Concepedia

Mechanisms of decreased Vitamin D 1α-hydroxylase activity in prostate cancer cells

Jian Feng, Larisa Nonn, Moray J. Campbell, Martin Hewison, David Feldman, Donna M. Peehl

Molecular and Cellular Endocrinology · 2004 · 46 citations · 23 references

DOI

Concepts

References

23

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

Merja Ahonen, Leena Tenkanen, L Teppo et al. · Cancer Causes & Control · 2000 · 490 citations

, , +14

Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.

Gary G. Schwartz, Lyman W. Whitlatch, Tai C. Chen et al. · PubMed · 1998 · 365 citations

, , +12

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

Elizabeth H. Corder, Harry A. Guess, Barbara S. Hulka et al. · PubMed · 1993 · 356 citations

, , +15

Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis.

Larisa Nonn, Margareta Berggren, Garth Powis · PubMed · 2003 · 216 citations

, , +16

Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition.

J Y Hsu, David Feldman, John E. McNeal et al. · PubMed · 2001 · 216 citations

, , +17